Industry News
REVA Medical recruiting in A/NZ for stent trial
REVA Medical (ASX:RVA) has commenced recruitment for the Australia/New Zealand arm of its CE Mark trial for ReZolve 2, a bioresorbable cardiac scaffold. [ + ]
AmpliPhi raises $7m in placement
AmpliPhi, the US bacteriophage company which merged with Australia’s Special Phage Services last year, has raised $7m in a private placement. [ + ]
Genetic variations found in people with allergies
Genetic differences between people who develop allergies and those who don’t have been identified. [ + ]
‘Inspiring industry to inspire Australia’ science appreciation report released
The report ‘Inspiring industry to inspire Australia’ has been released, highlighting 15 industry initiatives that are fostering an appreciation of science in schools, communities and the workforce, and its potential to improve our world. [ + ]
R&D Tax Bill introduced to parliament
A Bill was yesterday introduced into parliament to jointly legislate for quarterly credits for companies entitled to the refundable 45% R&D Tax Incentive and to enact the $20 billion turnover cap for companies to be eligible for the 40% non-refundable R&D tax offset, as announced as part of the government’s A Plan for Australian Jobs in February. [ + ]
Mesoblast gets ethics nod for diabetes trial
Mesoblast (ASX:MSB) has been granted ethics approval for a phase II trial of its mesenchymal precursor cells in patients with diabetic nephropathy. [ + ]
Researching sexual health in Indigenous Australian men
A PhD scholarship for Aboriginal and Torres Strait Islander students has been created by Andrology Australia. [ + ]
Strategic Research Priorities
In a whole-of-government approach to investing in research, the Australian Government announced 15 Strategic Research Priorities (SRPs) this week. [ + ]
LBT Innovations enters joint venture with Hettich
LBT Innovations (ASX:LBT) will enter a 50/50 JV with Switzerland’s Hettich to oversee final development and distribution of lab screening platform APAS. [ + ]
GTG hails breast cancer risk detection study
Genetic Technologies (ASX:GTG) says an Australian academic study supports the effectiveness of including genotypes used in its BREVAGen test to improve breast cancer risk assessment. [ + ]
Putting the brakes on bacterial biofilms
New insights into how bacteria colonise surfaces may help deal with biofilms that develop on implanted medical devices. [ + ]
Biotech’s industry conference returns to Qld: early bird about to close
With early-bird registrations about to close (28 June), preparations have kicked into top gear at AusBiotech as the team prepares to return the industry event of the year to Brisbane, Queensland, from 30 October-1 November 2013. [ + ]
Fifteen research priorities for Australia’s future
Fifteen Strategic Research Priorities (SRPs) were launched on Friday by Prime Minister Julia Gillard, Minister for Tertiary Education, Skills, Science and Research Dr Craig Emerson, Minister for Science and Research Senator Don Farrell and Australia’s Chief Scientist, Professor Ian Chubb. [ + ]
Vampire bat venom evades the immune system
Scientists led by The University of Queensland’s (UQ’s) Associate Professor Bryan Fry have found that vampire bat venom contains molecules capable of evading the victim’s immune system. [ + ]
Dolomite brings droplet device to market
University spin-out company Drop-Tech has developed Mitos Dropix, a droplet-on-demand sampler set to make it easy to produce extremely miniaturised droplet compartments with excellent control over their contents. [ + ]
